Greenland Mines (NASDAQ: GRML) announced the completion of a three-day multidisciplinary planning workshop for its Skaergaard Precious and Critical Metals Project in southeast Greenland, held June 22-24. The workshop brought together more than 15 international experts from GTK Mintec, the Geological Survey of Finland, SLR Consulting, WSP Denmark and other technical specialists to advance understanding of the orebody and processing pathways.
The company stated that the workshop produced an integrated plan for the 2026 field campaign, a refined metallurgical testing strategy, a framework for incorporating geotechnical and environmental data into mine design and permitting, and a long-term development roadmap extending toward a potential exploitation license. This initiative builds on existing collaborations with GTK Mintec, WSP Denmark and SLR Consulting, reflecting Greenland Mines' strategy of engaging leading international technical experts to advance the Skaergaard project.
The Skaergaard project is a key asset in Greenland Mines' mining division, which also includes the Sarfartoq neodymium-praseodymium rare earths project in southwest Greenland, subject to closing of a previously announced transaction. The company's broader strategy is centered on building a multi-asset platform with exposure to rare earth magnet materials, precious metals and selected midstream processing opportunities, while advancing its North Atlantic Critical Metals Corridor vision linking Greenland resources with allied downstream jurisdictions and industrial infrastructure.
The workshop focused on planning 2026 drilling, sampling and environmental programs and establishing a roadmap toward an Initial Assessment (IA) or Preliminary Economic Assessment (PEA). These assessments are critical steps in evaluating the economic viability of the project and moving toward a potential exploitation license. The involvement of experts from GTK Mintec, the Geological Survey of Finland, and other firms underscores the technical complexity and international interest in the Skaergaard deposit.
Greenland Mines operates two divisions: mining and biotech. The biotech division includes Klotho's KLTO-202 primary indication for ALS. However, the focus of this announcement is on the mining division's progress at Skaergaard. The company is listed on Nasdaq under the ticker GRML.
For more details, the full press release is available at https://ibn.fm/LP1cL. The latest news and updates relating to GRML can be found in the company's newsroom at https://ibn.fm/GRML.
